TY - JOUR
T1 - Complications Of Peri-Operative Ureteral Catheter Placement
T2 - Experience at A Major Cancer Center
AU - Geskin, Albert A.
AU - Westney, O. Lenaine
AU - Graber, William J.
AU - Smith, Thomas G.
AU - Chapin, Brian F.
AU - Gregg, Justin R.
N1 - Funding Information:
Funding: No Funding.
Publisher Copyright:
© 2021
PY - 2022/6
Y1 - 2022/6
N2 - Objective: To evaluate risks of peri-operative ureteral catheter placement in a consecutive patient-series. Methods: Patients who underwent peri-operative ureteral catheter placement at a single institution in 2018 were included. A retrospective review was conducted to evaluate patient and procedure related characteristics, including data on technique, perceived placement difficulty, operative details, and complications. Outcome Measurements and Statistical Analysis: Urologic complications within 30 days were evaluated using the Clavien-Dindo system. Statistical analysis for association was conducted using the X2 test or fisher's exact tests. Results: 413 patients were included. 50/413 (12.1%) cases had urologic complications within 30 days. 43 were Clavien-Dindo grade I-II. Six were grade III. 5/6 patients had oliguric, obstructive AKI. One had flank pain with hydronephrosis. Two patients each underwent placement of unilateral nephrostomy tube, bilateral double-J stent placement, and unilateral stent placement. One patient had a Grade V complication. They developed multi-system organ failure including renal failure with hydronephrosis.All patients who required re-intervention had bilateral peri-operative catheterization with use of a wire. Intraoperative difficulty with placement was associated with high-grade complication (P<.01)). Limitations include retrospective,single center study design. Conclusions: Rate of acute complication following ureteral catheter placement is 12%. 1.7% of patients develop post-operative ureteral obstruction requiring intervention within 30 days. Future studies are needed to determine patients most at risk for post-ureteral stent complication.
AB - Objective: To evaluate risks of peri-operative ureteral catheter placement in a consecutive patient-series. Methods: Patients who underwent peri-operative ureteral catheter placement at a single institution in 2018 were included. A retrospective review was conducted to evaluate patient and procedure related characteristics, including data on technique, perceived placement difficulty, operative details, and complications. Outcome Measurements and Statistical Analysis: Urologic complications within 30 days were evaluated using the Clavien-Dindo system. Statistical analysis for association was conducted using the X2 test or fisher's exact tests. Results: 413 patients were included. 50/413 (12.1%) cases had urologic complications within 30 days. 43 were Clavien-Dindo grade I-II. Six were grade III. 5/6 patients had oliguric, obstructive AKI. One had flank pain with hydronephrosis. Two patients each underwent placement of unilateral nephrostomy tube, bilateral double-J stent placement, and unilateral stent placement. One patient had a Grade V complication. They developed multi-system organ failure including renal failure with hydronephrosis.All patients who required re-intervention had bilateral peri-operative catheterization with use of a wire. Intraoperative difficulty with placement was associated with high-grade complication (P<.01)). Limitations include retrospective,single center study design. Conclusions: Rate of acute complication following ureteral catheter placement is 12%. 1.7% of patients develop post-operative ureteral obstruction requiring intervention within 30 days. Future studies are needed to determine patients most at risk for post-ureteral stent complication.
UR - http://www.scopus.com/inward/record.url?scp=85124414012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124414012&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2021.04.068
DO - 10.1016/j.urology.2021.04.068
M3 - Article
C2 - 34280440
AN - SCOPUS:85124414012
VL - 164
SP - 88
EP - 93
JO - Urology
JF - Urology
SN - 0090-4295
ER -